Kinney; Gene G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kinney; Gene G..The latest application filed is for "compositions for treating amyloidosis".

Company Profile

3.5.13

Kinney; Gene G. - Burlingame CA
Kinney; Gene G. - Berlingame CA US
Kinney; Gene G. - Collegeville PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monitoring immunotherapy of Lewy body disease from constipation symptoms Grant 11,191,832 - Kinney , et al. December 7, 2	2021-12-07
Compositions for Treating Amyloidosis App 20210079078 - KINNEY; Gene G. ; et al.	2021-03-18
Compositions For Treating Amyloidosis App 20190169280 - KINNEY; GENE G. ; et al.	2019-06-06
Use of tau to monitor immunotherapy Grant 9,272,030 - Black , et al. March 1, 2	2016-03-01
Use Of Tau To Monitor Immunotherapy App 20150118223 - Black; Ronald ; et al.	2015-04-30
Vaccine For The Treatment Of Alzheimer's Disease App 20110002949 - Savage; Mary J. ; et al.	2011-01-06
Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator App 20100144858 - Conn; P. Jeffrey ; et al.	2010-06-10
3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease Grant 6,855,829 - Dworetzky , et al. February 15, 2	2005-02-15
Cinnamide derivatives as KCNQ potassium channel modulators Grant 6,831,080 - Wu , et al. December 14, 2	2004-12-14
Novel imidazoline receptor homologs App 20030215916 - Feder, John N. ; et al.	2003-11-20
Cinnamide derivatives as KCNQ potassium channel modulators App 20030166650 - Wu, Yong-Jin ; et al.	2003-09-04
2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators App 20020183335 - Hewawasam, Piyasena ; et al.	2002-12-05
Novel Imidazoline receptor homologs App 20020161191 - Feder, John N. ; et al.	2002-10-31
Fluoro oxindole derivatives as modulators of KCNQ potassium channels App 20020156120 - Hewawasam, Piyasena ; et al.	2002-10-24
Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases App 20020128277 - Dworetzky, Steven I. ; et al.	2002-09-12

Company Registrations

SEC

0001564380

Kinney Gene G.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.